Registration fees for webinars are $175/member and $300/non-member unless otherwise noted in an event description.

NDHA is an approved provider of continuing education by the North Dakota Board of Examiners for Nursing Home Administrators.

COVID-19 Regulatory Revisions for Hospitals, Laboratories....

Date: 10/27/2020

9:00 AM - 10:00 AM

COVID-19 Regulatory Revisions for Hospitals, Laboratories and Long-Term Care Facilities

This webinar will cover the recent Centers for Medicare and Medicaid Services (CMS) Interim Final Rule on Medicare and Medicaid Programs, Clinical Laboratory Improvement Amendments (CLIA), and the Patient Protection and Affordable Care Act, with additional policy and regulatory revisions in response to COVID-19.

Target Audience:  CEO, Compliance Officer, Chief Medical Officer, Chief Nursing Officer, Nurse Education, Nurse Directors/Supervisors, Risk Managers, Patient Safety Officers, Quality Improvement staff, Infection Control Preventionist/Manager, Laboratory Director/Managers, Hospital Legal Counsel, QAPI Director

Detailed Program Outline

Review of Public Health Emergency and legislative response

  • History of regulations
  • Reasons for updates from CMS
  • Overview of key changes
  • Abbreviations used by CMS

Hospitals and Critical Access Hospitals

  • Overall changes with new regulations
  • Facilities affected under “Hospitals”
  • Authority of CMS
  • Conditions of Participation requirements
  • New regulations
  • Enforcement of new requirements
  • Other expectations from CMS
  • What Hospitals required to report and submit
  • Where and how to submit required data
  • Suggested actions

Laboratories

  • Overview of CLIA and oversight
  • CARES Act
  • June 4, 2020 Guidance
  • Key points of new regulation
  • Required data elements to be reported
  • Basics of Final Interim Rule
  • New Interim Rule Requirements and Modifications
  • Accrediting Organizations and Exempt States reporting
  • Suggested Actions

Long Term Care Facilities

  • Previous requirements
  • New Enforcement implications
  • Testing requirements
  • Restricted Access and Mitigation of Transmission
  • Parameters by Secretary
  • Testing generally
  • Additional requirements
  • Restricted access and mitigation of transmission
  • Patient and Staff rights
  • Suggested actions

Speaker:
Laura A. Dixon is the president of Healthcare Risk Education and Consulting. She previously served as the Director, Facility Patient Safety and Risk Management and Operations for COPIC from 2014 to 2020.  In her role, Ms. Dixon provided patient safety and risk management consultation and training to facilities, practitioners and staff in multiple states. Ms. Dixon has more than twenty years of clinical experience in acute care facilities, including critical care, coronary care, peri-operative services and pain management.  Prior to joining COPIC, she served as the Director, Western Region, Patient Safety and Risk Management for The Doctors Company, Napa, California.  In this capacity, she provided patient safety and risk management consultation to the physicians and staff for the western United States.  As a registered nurse and attorney, Laura holds a Bachelor of Science degree from Regis University, RECEP of Denver, a Doctor of Jurisprudence degree from Drake University College of Law, Des Moines, Iowa, and a Registered Nurse Diploma from Saint Luke’s School Professional Nursing, Cedar Rapids, Iowa.  She is licensed to practice law in Colorado and California.

Learning Objectives:
At the conclusion of the webinar, attendees will be able to:

  • Recall recent legislation, changes and updates for Acute and Critical Access Hospitals, Laboratories and Long-Term Care Facilities
  • Recount the rationales for the changes as it relates to patient care and safety
  • Discuss implications for noncompliance by various types of facilities and entities
  • Develop processes to implement measures to comply with applicable regulations